Back to results
US 2004/0082065 A1Published application
Use of stimulated peripheral-blood mononuclear cells for the treatment of cancerous diseases
OwnerRudolf Wankinventor
Life of this patent
Estimating the term…
Abstract
The invention relates to the use of peripheral-blood mononuclear cells that have been stimulated via cascade priming (CAPRI cells) for the purpose of providing an agent for the treatment of cancerous diseases. The CAPRI cells may also be administered in combination with CD3-activated cells.
Claims17
Use of peripheral-blood mononuclear cells that have been stimulated via cascade priming (capri cells), which are obtainable by the following stimulation process:
- peripheral-blood mononuclear cells (PBMC) are subjected to primary stimulation by means of agents that stimulate T-lymphocytes
- naïve PMBC are added to the PBMC that have been subjected to primary stimulation and are incubated for the purpose of stimulating the naïve PBMC, for the purpose of providing an agent for the treatment of cancerous diseases.
Dependencies are inferred from the claim text.